Lexeo Therapeutics (NASDAQ:LXEO) executives outlined the company’s focus on precision medicines for inherited cardiac diseases during a presentation at Oppenheimer’s 36th Annual Healthcare Life ...
Most standard SMAS facelifts show visible aging within years of the original surgery, but a New York facial plastic ...
Safety and efficacy evaluation of nadofaragene firadenovec instilled into the renal pelvis in subjects with low-grade upper tract urothelial carcinoma (LG-UTUC): A single-arm, open-label phase 1/2 ...
Plan your Fetch Charlotte schedule with these lectures to watch.
New research links PFAS — the 'forever chemicals' found in cookware, clothing, and drinking water — to accelerated biological ...
Metilience unveils a hybrid AI reasoning engine for high-stakes exams, leveraging structured cognitive error analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results